Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · Real-Time Price · USD
4.080
+0.060 (1.49%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Aileron Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cost of Revenue
-----17.66
Upgrade
Gross Profit
------17.66
Upgrade
Selling, General & Admin
16.3311.369.689.69.3312.29
Upgrade
Research & Development
9.23.9917.9717.0111.17-
Upgrade
Operating Expenses
25.5215.3527.6526.6120.512.29
Upgrade
Operating Income
-25.52-15.35-27.65-26.61-20.5-29.96
Upgrade
Interest & Investment Income
0.60.6---0.59
Upgrade
Other Non Operating Income (Expenses)
-0.34-0.090.32-0.010.08-
Upgrade
EBT Excluding Unusual Items
-25.26-14.84-27.33-26.62-20.42-29.37
Upgrade
Merger & Restructuring Charges
0.01-0.93----
Upgrade
Gain (Loss) on Sale of Assets
0.040.04-0.070.09-
Upgrade
Other Unusual Items
---0.39-0.82-
Upgrade
Pretax Income
-25.22-15.73-27.33-26.16-21.16-29.37
Upgrade
Net Income
-25.22-15.73-27.33-26.16-21.16-29.37
Upgrade
Net Income to Common
-25.22-15.73-27.33-26.16-21.16-29.37
Upgrade
Shares Outstanding (Basic)
955421
Upgrade
Shares Outstanding (Diluted)
955421
Upgrade
Shares Change (YoY)
107.31%1.31%2.23%154.70%42.11%66.48%
Upgrade
EPS (Basic)
-2.68-3.42-6.02-5.89-12.14-23.94
Upgrade
EPS (Diluted)
-2.68-3.42-6.02-5.89-12.14-23.94
Upgrade
Free Cash Flow
-25.69-19.81-24.87-23.91-20.48-26.63
Upgrade
Free Cash Flow Per Share
-2.73-4.31-5.48-5.38-11.75-21.70
Upgrade
EBITDA
-25.4-15.23-27.48-26.48-20.33-29.8
Upgrade
D&A For EBITDA
0.130.120.170.120.160.16
Upgrade
EBIT
-25.52-15.35-27.65-26.61-20.5-29.96
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.